drugset / Trial / NCT01233739
Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Patients who present rhizarthrosis diagnostic will be randomized to be treated with chondroitin sulfate or placebo during 24 weeks to study the effect of the treatment with objective and subjective indicators of pain and sensibility.
Timeline
- Start
- 2011-03
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chondroitin sulfate | Unknown | 800 mg | Oral |